MedTrace Logo

Nordic Hamstring and Repeated-sprint Ability in Football (Soccer) Players

NCT02674919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-06-14

No results posted yet for this study

Summary

The purpose of the study is to investigate the efficacy of a 10-week intervention, using the Nordic Hamstring exercise, on repeated-sprint ability in male sub-elite football players. The primary outcome measure is total sprint time during 4x6 sprint of 10 meters measured using dual-beam photoelectric cells. Additionally, eccentric knee flexor strength is measured using the Nordbord hamstring strength measure. The hypothesis is that strength training of the knee flexor muscles elicited by the Nordic Hamstring exercise will result in enhanced repetitive sprint-ability expressed as a decrease in total sprint time. Furthermore, baseline data is used to assess to correlation between eccentric hamstring strength and active hamstring flexibility AND sprint performance.

Conditions

  • Repeated-sprint Ability

Interventions

OTHER

Nordic Hamstring

OTHER

Control

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Aspetar

    collaborator OTHER

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Lasse Ishøi · Hvidovre University Hospital. University of Southern Denmark

  • Per Hölmich · Hvidovre University Hospital. Aspetar

  • Per Aagaard · University of Southern Denmark

  • Kristian Thorborg · Hvidovre University Hospital

  • Thomas Bandholm · Hvidovre University Hospital

  • Andreas Serner · Hvidovre University Hospital. Aspetar

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674919 on ClinicalTrials.gov